Abstract:Schizophrenia is a severe neuropsychiatric disorder with core features including hallucinations, delusions, and cognition deficits. Accumulating evidence has implicated abnormal DNA methylation in the development of schizophrenia. However, the mechanisms by which DNA methylation changes alter the risk for schizophrenia remain largely unknown. We recently carried out a DNA methylome study of peripheral blood samples from 469 first-episode patients with schizophrenia and 476 age- and gender-matched healthy controls of Han Chinese origin. Genomic DNA methylation patterns were quantified using an Illumina Infinium Human MethylationEPIC BeadChip. We identified multiple differentially methylated positions (DMPs) and regions between patients and controls. The most significant DMPs were annotated to genes C17orf53, THAP1 and KCNQ4 (KV7.4), with Bonferroni-adjusted P values of ({mathrm{1}}{mathrm{.34}} imes {mathrm{10}}^{{mathrm{ - 12}}}), ({mathrm{1}}{mathrm{.15}} imes {mathrm{10}}^{{mathrm{ - 11}}}), and ({mathrm{3}}{mathrm{.11}} imes {mathrm{10}}^{{mathrm{ - 11}}}), respectively. In particular, KCNQ4 encodes a voltage-gated potassium channel of the KV7 family, which is linked to neuronal excitability. The genes associated with top-ranked DMPs also included many genes involved in nervous system development, such as LIMK2 and TMOD2. Gene ontology analysis of the differentially methylated genes further identified strong enrichment of neuronal networks, including neuron projection extension, axonogenesis and neuron apoptotic process. Finally, we provided evidence that schizophrenia-associated epigenetic alterations co-localize with genetic susceptibility loci. By focusing on first-episode schizophrenia patients, our investigation lends particularly strong support for an important role of DNA methylation in schizophrenia pathogenesis unconfounded by the effects of long-term antipsychotic medication or disease progression. The observed DNA methylation aberrations in schizophrenia patients could potentially provide a valuable resource for identifying diagnostic biomarkers and developing novel therapeutic targets to benefit schizophrenia patients.

Substantial Dna Methylation Differences Between Two Major Neuronal Subtypes In Human Brain

DNA Methylation in Schizophrenia: Progress and Challenges

Cell-type specific DNA methylome signatures reveal epigenetic mechanisms for neuronal diversity and neurodevelopmental disorder

Single-cell DNA methylation and 3D genome architecture in the human brain

Genetic control of individual differences in gene-specific methylation in human brain.

Diversity of Two Forms of DNA Methylation in the Brain

Divergent Neuronal DNA Methylation Patterns Across Human Cortical Development Reveal Critical Periods and a Unique Role of CpH Methylation

Genome-wide DNA methylation analysis of human brain tissue from schizophrenia patients

DNA Methylation Differences in Cortical Grey and White Matter in Schizophrenia.

Genome-wide Antagonism Between 5-Hydroxymethylcytosine and DNA Methylation in the Adult Mouse Brain

Subtypes of schizophrenia identified by multi-omic measures associated with dysregulated immune function

Genome-wide DNA methylation analyses in the brain reveal four differentially methylated regions between humans and non-human primates

Epigenomic complexity of the human brain revealed by single-cell DNA methylomes and 3D genome structures

Neuronal and Glial 3D Chromatin Architecture Informs the Cellular Etiology of Brain Disorders

Epigenetic heterogeneity shapes the transcriptional landscape of regional microglia

Correlation between DNA methylation and gene expression in the brains of patients with bipolar disorder and schizophrenia.

Genome-wide DNA methylation analysis of peripheral blood cells derived from patients with first-episode schizophrenia in the Chinese Han population

Temporally distinct 3D multi-omic dynamics in the developing human brain

Non-CG DNA methylation and MeCP2 stabilize repeated tuning of long genes that distinguish closely related neuron types

Whole-genome analysis of 5-hydroxymethylcytosine and 5-methylcytosine at base resolution in the human brain

Identification of methylation and hydroxymethylation haplotype blocks as distal regulatory elements aids in deconvolution of heterogeneous brain tissues